Pre-COVID adherence in people taking oral diabetes medication in the UK was reported to range from 60% (Tunceli et al. 2015) to 87% (Farmer et al. 2015), with 71% adherence to insulin) (Donnelly et al. 2007) compared with 74.6% for the two categories combined in this study. This evidence concerns the gene INS and diabetes mellitus.